Effect of Nintedanib in Patients with Progressive Pulmonary Fibrosis in Subgroups with Differing Baseline Characteristics.
Martin R J KolbKevin R FlahertyRafael S SilvaAntje PrasseCarlo VancheriHeiko MuellerKamila Sroka-SaidiAthol U Wellsnull nullPublished in: Advances in therapy (2023)
ClinicalTrials.gov Identifier: NCT02999178.